azacitidine,enasidenib
servier
['leukemia', 'beat aml', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'lymphoma', 'master trial']
news from #ash22: the beat aml master clinical trial is showing superior survival rates and better quality of life when genomic analysis is used to match patients to gentler, targeted therapies. 
Since 1949, we’re unstoppable in the fight against blood cancer. https://t.co/iUaB1KzuMq #CancelBloodCancer